Hirudin for the Improvement of Thrombolysis - HIT-I

Description:

HIT-I was a pilot study to determine the feasibility, efficacy, and safety of recombinant hirudin as adjunctive therapy to thrombolysis with t-PA in patients with ST elevation myocardial infarction.